CTMR aims to better understand the contribution of the human microbiome to physiology and pathophysiology with the goal to open opportunities for development of novel therapies in the area of gastroenterology, reproductive health and neonatology.
CTMR receives European funding through the Horizon 2020 framework and the ONCOBIOME project
CTMR, under the lead of Professor Lars Engstrand, has received European funding through the Horizon 2020 framework and is one of the 17 collaborators of the ONCOBIOME project (2019-2023). This ONCOBIOME project aims to explore the role of the microbiome in cancer, from early detection and diagnosis to treatment and prognosis.“
More information about the EU collaborative projects